Abstract. Epithelial-to-mesenchymal transition (EMT) is defined as phenotypic change of epithelial cells into mesenchymal cells. EMT, allowing cellular dissociation from epithelial tissues, plays a key role in invasion and metastasis during carcinogenesis as well as in gastrulation and neurulation during embryogenesis. SNAI1/Snail, SNAI2/Slug, ZEB1/‰EF1/ ZFHX1A, ZEB2/SIP1/ZFHX1B, TWIST1/TWIST, and TWIST2/DERMO1 are representative EMT regulators. ZEB2 represses transcription of CDH1, CLDN4, CCND1, TERT, SFRP1, ALPL and miR-200b-200a-429 primary miRNA, and upregulates transcription of mesenchymal markers. ZEB2 is relatively highly expressed in brain corpus callosum and monocytes. ZEB2 is expressed in various types of human tumors, such as breast cancer, gastric cancer, and pancreatic cancer. TGFß, TNF·, IL1, AKT and hypoxia signals are involved in ZEB2 upregulation and EMT induction; however precise mechanisms of ZEB2 transcription remained unclear. Here, refined integrative genomic analyses of ZEB2 gene were carried out. ZEB2 was co-expressed with POU3F2 (BRN2) and POU3F3 (BRN1) in brain corpus callosum, spinal cord, and fetal brain, whereas ZEB2 was co-expressed with POU2F2 (OCT2) in monocytes. Ets-Smad-binding CGGAGAC motif, bHLH-binding site, and POU/OCT-binding site within proximal promoter region, and NF-κB-binding site within intron 2 were completely conserved in human ZEB2, chimpanzee ZEB2, cow ZEB2, mouse Zeb2, rat Zeb2, and chicken zeb2 genes. In addition, HIF1·-binding site within proximal promoter region was conserved in mammalian ZEB2 orthologs. Consensus binding site for Hedgehog effector GLI was not identified within or adjacent to the 7-kb regions of human ZEB2 gene. TGFß, TNF·, IL1, and hypoxia signals directly upregulate ZEB2 to induce EMT, growth arrest, and senescence, whereas Hedgehog signals indirectly upregulate ZEB2 via TGFß. Together these facts indicate that ZEB2, occupying the crossroads of inflammation, aging and carcinogenesis, is an important target for drug discovery.
Introduction
Epithelial-to-mesenchymal transition (EMT) is defined as phenotypic change of epithelial cells into mesenchymal cells (1) (2) (3) (4) . Epithelial cells with E-cadherin expression are tightly held together with uniform neighboring cells to move as a sheet en block, whereas mesenchymal cells without E-cadherin expression are loosely connected with diverse neighboring cells to move individually. EMT, allowing cellular dissociation from epithelial tissues, plays a key role in invasion and metastasis during carcinogenesis as well as in gastrulation and neurulation during embryogenesis.
Downregulation of E-cadherin at the adherens junction and Claudin at the tight junction leads to the loss of epithelial phenotype, while upregulation of N-cadherin and Vimentin leads to the acquisition of mesenchymal phenotype. SNAI1/ Snail (5), SNAI2/Slug (6), SNAI3 (7), ZEB1/‰EF1/ZFHX1A (8) , ZEB2/SIP1/ZFHX1B (9), TWIST1/TWIST (10) , and TWIST2/DERMO1 (11) are representative EMT regulators. Upregulation of EMT regulators in tumor cells is associated with more malignant phenotypes in a variety of human cancer (12) (13) (14) (15) (16) .
ZEB2 and ZEB1 are transcription factors with common domain architecture consisting of the p300-binding domain and four zinc finger domains in the N-terminal region, Smadbinding domain, Homeo domain and CtBP-binding domain in the middle region, and three zinc finger domains in the C-terminal region (17, 18) . ZEB2 is involved in transcriptional repression of CDH1 (9) , ALPL (19) , TERT (20) , CLDN4 (21), CCND1 (22) , SFRP1 (23) and miR-200b-200a-429 primary miRNA (24) through the recruitment of CtBP co-repressor. ZEB2 is also involved in transcriptional activation of mesenchymal markers through the recruitment of p300 coactivator in cooperation with SMAD complex or through indirect mechanisms.
ZEB2 is expressed in various types of human tumors, including breast cancer (9, (25) (26) (27) , gastric cancer (13, 15) , colorectal cancer (28) , liver cancer (29, 30) , ovarian cancer (25), oral squamous cell carcinoma (31,32), pancreatic cancer (33) , and kidney cancer (34), as summarized in Table I .
Because ZEB2 is one of key molecules involved in carcinogenesis, refined integrative genomic analyses of ZEB2 gene were carried out in this study to elucidate the mechanisms of ZEB2 transcription.
Materials and methods
Comparative genomic analyses. Human genome sequences corresponding to human ZEB2 RefSeq (NM_014795.2) were searched for by using BLAST programs, as previously described (35, 36) . ZEB2 expressed sequence tags (ESTs) were also searched for to identify ZEB2 splicing variants (37, 38) . Conserved transcription factor-binding sites within ZEB2 promoters were then searched for based on manual inspection, as previously described (39, 40) .
Regulatory network analyses. Literature on ZEB2, NF-κB, TGFß, Notch and Hedgehog signaling molecules in PubMed and Medline databases was critically evaluated to extract knowledge on the regulation of NF-κB, SMAD, CSL, GLI and FOX transcription factors. The mechanisms of ZEB2 transcription were then investigated based on our data of conserved transcription factor-binding sites within ZEB2 promoters and in-house knowledgebase of transcription factors regulated by the stem-cell signaling network.
Results

ZEB2
splicing variants transcribed by using alternative promoters. BLAST programs using ZEB2 RefSeq (NM_014795.2) as a query sequence revealed that the ZEB2 gene was located within human genome sequences AC009951.10 and AC010130.12. Human ZEB2 gene, consisting of 10 exons, was found to be about 132 kb in size, and intron 2 was about 87 kb in size (Fig. 1) . BLAST programs using human ZEB2 genome sequence as a query sequence revealed that more than 50 ESTs were transcribed based on the major promoter, 5'-adjacent to exon 1, and that two ESTs were transcribed based on the minor promoter, 5'-adjacent to exon 2 (data not shown).
Comparative genomic analyses of ZEB2 orthologs. BLAST programs using human ZEB2 genome sequence as a query sequence next revealed that chimpanzee ZEB2 gene, cow ZEB2 gene, mouse Zeb2 gene, rat Zeb2 gene, and chicken zeb2 gene were located within NW_001232106.1, NW_001494615.2, NT_039206.7, NW_047654.1, and NW_001471733.1 genome sequences, respectively. ZEB2 orthologs were well conserved not only within exonic regions, but also within the major promoter region and intronic regions (data not shown).
TGFß signaling and ZEB2. TGFß-binding to TGFß receptors leads to autophosphorylation of cytoplasmic serine-kinase domain of TGFß receptors, which results in phosphorylation of Smad2 or Smad3 signal transducer, and transcriptional activation of TGFß-target genes based on the Smad2-Smad4 or Smad3-Smad4 complex (41, 42) . TGFß signaling cascades are involved in ZEB2 upregulation and EMT (20, 43, 44) ; however, precise mechanisms of TGFß-induced ZEB2 upregulation remain to be elucidated.
Multiple Smad-binding elements were identified within human ZEB2 promoter based on manual inspection (data not shown). TGFß signals and Ets1 are known to synergistically upregulate transcription of target genes involved in invasion and metastasis (45) . The CGGAGAC motif, corresponding to Table I . ZEB2 expression in human tumors.
Expression and mechanism Author/(Refs.) 
Ets-and Smad-binding sites located at the -8 bp position from the transcriptional start site (TSS) of human ZEB2 RefSeq was completely conserved in chimpanzee ZEB2, cow ZEB2, mouse Zeb2, rat Zeb2, and chicken zeb2 genes (Fig. 1) .
Hedgehog signaling and ZEB2. Hedgehog-binding to Patched receptors leads to activation of Smoothened signaling, which results in transcriptional activation of Hedgehog target genes via GLI activators (46) (47) (48) . Hedgehog signaling cascades are also involved in EMT (4, 49) . Consensus GLI-binding site was not identified within the 10-kb upstream region from the TSS of human ZEB2 RefSeq as well as within the ZEB2 gene (data not shown). Therefore, Hedgehog-GLI signaling cascades are predicted to be involved in indirect rather than direct transcriptional activation of ZEB2.
Hypoxia signaling and ZEB2. HIF1 complex, consisting of HIF1· and HIF1ß/ARNT, is involved in cellular response to hypoxia through transcriptional regulation of genes involved in energy metabolism, angiogenesis, apoptosis, and EMT (50, 51) . HIF1· undergoes ubiquitin-mediated proteasomal degradation under normoxic condition to inhibit HIF1 activity, whereas HIF1· is stabilized under hypoxic condition to activate HIF1 activity. Hypoxia-induced HIF1· upregulation leads to invasion and metastasis of tumor cells through upregulation of EMT regulators, such as SNAI1, ZEB1, ZEB2, and TWIST1 (52, 53) .
Because the transcriptional mechanisms of HIF1-induced ZEB2 upregulation remain unknown, HIF1·-binding site (hypoxia response element) within ZEB2 promoter was next searched for. HIF1·-binding site was identified at the -876-bp position from the TSS of human ZEB2 RefSeq. The HIF1·-binding site within the proximal promoter region of human ZEB2 gene was conserved in chimpanzee ZEB2, cow ZEB2, mouse Zeb2, and rat Zeb2 genes (Fig. 1) .
NF-κB signaling and ZEB2. NF-κB is a key transcription factor involved in inflammation and carcinogenesis (54-56).
Because IκB tethers NF-κB in the cytoplasm to prevent its nuclear translocation and subsequent transcriptional activation of target genes, IKK-induced phosphorylation of IκB leads to its ubiquitin-mediated proteasomal degradation, and NF-κB activation. TNF·, IL1, and TGFß signals activate IKK via MAP3K7, whereas PI3K signals activate IKK via AKT.
Chua et al reported that TNF·, IL1 and AKT induce NF-κB activation, ZEB2 upregulation and EMT in human MCF-10A cells, while TNF· and IL1 induce ZEB2 upregulation in human MD-231 cells (57). Julien et al reported that NF-κB-binding site is not located within the human ZEB2 promoter (58) . We confirmed the absence of NF-κB-binding site within the 10-kb upstream region from the TSS of human ZEB2 RefSeq (data not shown). Moreover, we identified an NF-κB-binding site within the proximal promoter region of the mouse Zeb2 gene; however, the NF-κB-binding site within the mouse Zeb2 promoter was not conserved in human ZEB2 and rat Zeb2 promoters (data not shown).
To elucidate the mechanisms of NF-κB-mediated human ZEB2 upregulation, we next searched for NF-κB-binding sites within the ZEB2 gene or the 3'-adjacent region of the ZEB2 gene. Triple NF-κB-binding sites were identified within intron 2 of the human ZEB2 gene (data not shown). The first NF-κB-binding site at the position about 59-kb downstream from the TSS of human ZEB2 RefSeq was conserved in chimpanzee ZEB2, cow ZEB2, mouse Zeb2, rat Zeb2, and chicken zeb2 genes (Fig. 1) . The second NF-κB-binding site at the position about 66-kb down stream from the TSS of human ZEB2 RefSeq was conserved in chimpanzee ZEB2, cow ZEB2, and mouse Zeb2 genes, while the third NF-κB-binding site at the position about 72-kb downstream from the TSS of human ZEB2 RefSeq was conserved in chimpanzee ZEB2, and mouse Zeb2 genes (data not shown). Because the first NF-κB-binding site within intron 2 of ZEB2 orthologs was ultra-conserved in mammals and chicken (Fig. 1) , it was concluded that the first NF-κB-binding site within intron 2 is involved in NF-κB-mediated ZEB2 upregulation.
Other transcription factor-binding sites. After the identification of evolutionarily conserved Ets-Smad-, HIF1·-and NF-κB-binding sites, we then searched for other transcription factorbinding sites by using the Genetyx program. bHLH-binding site at the -940 bp position from the TSS of human ZEB2 RefSeq was conserved in chimpanzee ZEB2, cow ZEB2, mouse Zeb2, rat Zeb2, and chicken zeb2 genes, while POU (OCT)-binding site at the -876 bp position from the TSS of human ZEB2 RefSeq was conserved in chimpanzee ZEB2, cow ZEB2, mouse Zeb2, and rat Zeb2 genes (Fig. 1) .
Discussion
Refined integrative genomic analyses of ZEB2 gene were carried out in this study. Ets-Smad-binding CGGAGAC motif, bHLH-and POU/OCT-binding sites within the proximal promoter region, and NF-κB-binding site within intron 2 were completely conserved in human ZEB2, chimpanzee ZEB2, cow ZEB2, mouse Zeb2, rat Zeb2, and chicken zeb2 genes (Fig. 1) . In addition, HIF1·-binding site within the proximal promoter region was conserved in mammalian ZEB2 orthologs (Fig. 1) . TGFß signals activate ZEB2 transcription via Smads, Ets1, and NF-κB; TNF· and IL1 signals activate ZEB2 transcription via NF-κB; Hypoxia signals activate ZEB2 transcription via HIF1· (Fig. 2) . Together these facts indicate that TGFß, TNF·, IL1, and hypoxia signals directly upregulate ZEB2.
Hedgehog-GLI signaling cascades cross-talk with TGFß, WNT, FGF, and Notch signaling cascades to constitute the stem-cell signaling network (59-62). Consensus GLI-binding site was not identified within or adjacent to the 7-kb regions (Fig. 2) , whereas Hedgehog signals are predicted to indirectly upregulate ZEB2 via TGFß.
POU-binding site within the proximal promoter region of human ZEB2 gene was conserved in mammals and chicken (Fig. 1) . To investigate the relationship between POU-domain transcription factor and ZEB2 transcription, POU family members co-expressed with ZEB2 were also searched for in this study. POU3F2 (BRN2) and POU3F3 (BRN1) were coexpressed with ZEB2 in brain corpus callosum, spinal cord, and fetal brain, whereas POU2F2 (OCT2) was co-expressed with ZEB2 in monocytes (RefEX database). Involvement of POU family members in ZEB2 transcription in corpus callosum and monocytes should be further investigated in the future.
Heterozygous deletions or truncating mutations of human ZEB2 gene give rise to Mowat-Wilson syndrome, manifesting mental retardation, epilepsy, and variable congenital malformations including microcephaly, agenesis of the corpus callosum, Hirschsprung disease, congenital heart disease, hypospadias, genitourinary anomalies, short stature, and characteristic facial features (64) . Mouse Zeb2 is expressed in neural crest and neural epithelium at embryonic day 8.5, and Zeb2 knockout mice show phenotypes similar to human Mowat-Wilson syndrome (65) . Because ZEB2 is one of key regulators of EMT, germline mutations of the ZEB2 gene results in multiple congenital malformations due to the migratory failure of neural crest cells.
Monocytes differentiate into macrophages or dendritic cells to function as antigen presenting cells regulating innate and adaptive immune responses (66, 67) . ZEB2 is more highly expressed in monocytes than in macrophages, whereas Smad7, functioning as an inhibitor for Smad2 and Smad3, is relatively higher expressed in macrophages than in monocytes (RefEX database). Because cellular adhesion and proliferation are promoted during differentiation of monocytes into macrophages (68), Smad7-mediated inhibition of TGFß signaling leads to ZEB2 downregulation to induce phenotypic changes from monocytes to macrophages.
EMT in physiological conditions is associated with dedifferentiation and growth arrest (69) . ZEB2 induces direct transcriptional repression of the CCND1 gene, encoding Cyclin D1 (22) , and TERT gene, encoding catalytic subunit of telomerase (20) . Because constitutive downregulation of Cyclin D1 and telomerase is not preferable for tumor cells, mesenchymalepithelial transition (MET) accompanied by ZEB2 downregulation should occur in tumor cells at the metastasized organs to recover the expression of Cyclin D1 and telomerase.
ZEB2 also represses the SFRP1 gene, encoding an endogenous WNT signaling inhibitor (23) . Hedgehog signals induce direct upregulation of SFRP1 gene in the earlier phase (70) (71) (72) , whereas Hedgehog signals might induce indirect down-regulation of SFRP1 gene in the later phase through the TGFß-ZEB2 signaling cascade in some situations.
This study demonstrated that TGFß, TNF·, IL1, and hypoxia signals directly upregulate ZEB2 to induce EMT, growth arrest, and senescence. Personalized medicine is gradually gaining practicality in parallel with the development of next-generation sequence technology and the peta-scale super-computer (73) . Because ZEB2 occupies the crossroads of inflammation, aging and carcinogenesis, ZEB2 should be an important target for drug discovery to promote personalized medicine.
